This study utilized a retrospective comparative cohort approach, aided by large scale propensity score modeling, to examine the association between use of prolactin increasing antipsychotics and the risk of incident breast cancer in patients diagnosed with schizophrenia. Here, PRL is linked to breast carcinoma.